INDEPENDENT CONTRACTOR AGREEMENTIndependent Contractor Agreement • February 20th, 2024 • Akanda Corp. • Medicinal chemicals & botanical products • British Columbia
This Independent Contractor Agreement (“Agreement”), effective as of ___________________, (the “Effective Date”), is between Akanda Corp. (“Company”) and Kiran Sidhu (“Contractor”).
NON-BINDING LETTER OF INTENTLetter of Intent • February 20th, 2024 • Akanda Corp. • Medicinal chemicals & botanical products
This letter of intent (“Letter of Intent”) is presented further to the discussions to date between Holigen Limited (the “Seller”), a subsidiary of Akanda Corp. (“Akanda”) and Somai Pharmaceuticals Ltd (“Somai” or the “Buyer”) or an affiliate. The Buyer understands that the Seller is the legal owner of all of the issued and outstanding shares in the capital of RPK Biopharma, Unipessoal, LDA (“RPK”, or the “Corporation”) or its affiliates. The key assets of RPK being all of its assets in Portugal, more specifically but not limited to; RPK’s Sintra facilities and licenses, including GACP, GMP and any other relevant licenses, RPK’s Aljustrel facilities and licenses including GACP, GMP and other relevant licenses, all related equipment, product inventory, commercial agreements, and all Intellectual Property. The provisions of this Letter of Intent will confirm the interest of the parties with respect to the Buyer’s proposed purchase, from the Seller, of all the issued and outstanding shares
AMENDMENT NO. 1 TO NON-BINDING LETTER OF INTENTNon-Binding Letter of Intent • February 20th, 2024 • Akanda Corp. • Medicinal chemicals & botanical products
This Amendment No. 1 to Non-Binding Letter of Intent (“Amendment”) is entered into and made effective as of January 31, 2024 by and between Akanda Corp. (“Akanda”) and Somai Pharmaceuticals Ltd. (“Somai”). Akanda and Somai are collectively referred to as the “Parties” and singularly referred to as “Party.”
Note Conversion Agreement July 25, 2023Note Conversion Agreement • February 20th, 2024 • Akanda Corp. • Medicinal chemicals & botanical products
This Note Conversion Agreement (the “Agreement”) is made as of July 25, 2023 between Halo Collective Inc., an Ontario corporation (the “Holder”), and Akanda Corp., an Ontario corporation (the “Debtor”), in connection with a promissory note with a principal amount of US$328,000 dated January 26, 2023 issued by the Debtor to the Holder (the “Note”).
